"Neoplasm Invasiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
| Descriptor ID |
D009361
|
| MeSH Number(s) |
C04.697.645 C23.550.727.645
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Invasiveness".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Invasiveness".
This graph shows the total number of publications written about "Neoplasm Invasiveness" by people in this website by year, and whether "Neoplasm Invasiveness" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 4 | 4 |
| 1999 | 1 | 5 | 6 |
| 2000 | 0 | 8 | 8 |
| 2001 | 0 | 7 | 7 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 5 | 7 |
| 2004 | 3 | 7 | 10 |
| 2005 | 0 | 11 | 11 |
| 2006 | 1 | 13 | 14 |
| 2007 | 4 | 12 | 16 |
| 2008 | 1 | 14 | 15 |
| 2009 | 3 | 16 | 19 |
| 2010 | 1 | 12 | 13 |
| 2011 | 2 | 15 | 17 |
| 2012 | 1 | 26 | 27 |
| 2013 | 2 | 19 | 21 |
| 2014 | 1 | 26 | 27 |
| 2015 | 2 | 29 | 31 |
| 2016 | 1 | 16 | 17 |
| 2017 | 1 | 17 | 18 |
| 2018 | 3 | 19 | 22 |
| 2019 | 1 | 16 | 17 |
| 2020 | 0 | 13 | 13 |
| 2021 | 1 | 9 | 10 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
| 2024 | 3 | 7 | 10 |
| 2025 | 0 | 7 | 7 |
| 2026 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent. Sci Adv. 2026 Sep 11; 12(37):eadz6815.
-
Treatment Type and Mortality for Black Versus White Patients With Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2026 Oct; 24(7):102626.
-
Morphologic Fault Lines in Distinguishing Gastric Cancer pTis From pT1a in Endoscopic Submucosal Dissection Specimens: An Interobserver Study. Pathol Int. 2026 Jun; 76(6):e70132.
-
Spatiotemporal Organization of PTK7 Diffusion on Cell Surface Facilitates Tumor Invasion and Migration. Adv Sci (Weinh). 2026 May; 13(26):e17876.
-
Commission on Cancer Quality Measure for Omission of Sentinel Lymph Node Biopsy (SNB) in Women Age 70 or Older with Hormone Receptor-Positive (HR+) Invasive Breast Cancer (IBC) Undergoing Breast-Conserving Surgery (BCS): Review of Historical Performance. Ann Surg Oncol. 2026 Jun; 33(6):5524-5532.
-
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med. 2026 Apr 02; 394(13):1257-1269.
-
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer. J Clin Oncol. 2026 02; 44(4):274-285.
-
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer. J Urol. 2026 01; 215(1):44-56.
-
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer. Urol Oncol. 2025 Nov; 43(11):660.e1-660.e10.
-
Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists. Am J Surg Pathol. 2025 Dec 01; 49(12):1307-1314.